Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Emisphere Technologies, Inc. (NASDAQOTCBB:EMIS)

CAPS Rating: 1 out of 5

A biopharmaceutical company specializing in the oral delivery of therapeutic macromolecules and other compounds that are poorly deliverable by oral means.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

50 Outperform
45 Underperform
 

All-Star Players

6 Outperform
19 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTCBB:EMIS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

rajny (< 20)
Submitted October 21, 2010

I can't argue with the thumbs-down pitches. This stock has held promise and has disappointed for years.However, if someone is looking for a high-risk, potentially high reward stock, EMIS is the biotech to look at...especially because it has been… More

TSIF (99.99)
Submitted February 11, 2019

May have some potential working with Novo Nordisk on applying their technology to oral insulin, but the low overhead from the (six) cited employees is being offset by the very high debt load. Data/Filings look stale, but last posted they had a neg… More

NASDAQOTCBB:EMIS VS S&P 500 (SPY)

Fools bullish on NASDAQOTCBB:EMIS are also bullish on:

Fools bearish on NASDAQOTCBB:EMIS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EMIS.

Recs

0
Member Avatar kdakota630 (29.48) Submitted: 2/22/2019 10:32:37 AM : Underperform Start Price: $3.05 NASDAQ OTC:EMIS Score: -126.24

Whoa, Nellie, not so fast fella. No way! Back to reality. Not a good pick. Not now. Wrong logic at this point. Gravity calls. Watch out on this one. Not at all optimistic. Pessimism reigns. Downward trend continues. Likely to continue to underperform. Look out below. More downside imminent. Danger danger, at least for the next month. So obvious.

Recs

2
Member Avatar TSIF (99.99) Submitted: 2/11/2019 1:17:18 PM : Underperform Start Price: $3.40 NASDAQ OTC:EMIS Score: -101.64

May have some potential working with Novo Nordisk on applying their technology to oral insulin, but the low overhead from the (six) cited employees is being offset by the very high debt load.
Data/Filings look stale, but last posted they had a
neg -155M in book, they aren't worth a $200M Market cap.

OTC company.

Target 20+ points

Recs

0
Member Avatar SmartAce (99.98) Submitted: 12/3/2018 10:53:39 AM : Underperform Start Price: $2.35 NASDAQ OTC:EMIS Score: -202.50

Hung my Christmas lights on the house across the street so I can see them.

Leaderboard

Find the members with the highest scoring picks in EMIS.

Score Leader

MATTEH

MATTEH (63.65) Score: +398.85

The Score Leader is the player with the highest score across all their picks in EMIS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
MATTEH 63.65 9/20/2010 Outperform 5Y $1.10 +595.45% +196.60% +398.85 0 Comment
rajny < 20 10/19/2010 Outperform 5Y $1.17 +553.85% +185.98% +367.87 1 Comment
runway2 < 20 3/21/2011 Outperform 1Y $1.60 +378.12% +159.58% +218.55 0 Comment
Pilarchard 96.08 10/23/2006 Underperform 5Y $9.98 -23.35% +160.42% +183.77 0 Comment
astrodogind 94.88 10/16/2006 Underperform 5Y $9.66 -20.81% +161.93% +182.74 4 Comments
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. DesiCluB90 49.39 11/15/2010 Outperform 5Y $1.72 +344.77% +179.38% +165.38 0 Comment
bwedeking 76.63 10/30/2006 Underperform NS $7.20 +6.25% +159.85% +153.60 0 Comment
TMFNosediveflip 93.61 10/31/2006 Underperform 1Y $6.86 +11.52% +158.92% +147.40 0 Comment
msonif < 20 11/3/2006 Underperform 3W $5.99 +27.71% +160.49% +132.77 0 Comment
h20diver < 20 11/3/2006 Underperform 3W $5.58 +37.10% +160.87% +123.77 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EMIS.